Klebsiella pneumoniae, a bacterium found in the gut, may reach the brain and affect Alzheimer's disease progression, research ...

An elderly patient died in a clinical study of Roche Holding AG’s experimental treatment for Alzheimer’s disease, prompting ...

Braisted said wandering is a risk for every person living with Alzheimer's or other dementias. "So, it's really important to ...

An Alzheimer’s drug from Roche cleared a protein that’s a hallmark of the disease from patients’ brains, suggesting the drug ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...

Coya Therapeutics said on Tuesday its experimental Alzheimer's drug was safe and increased levels of a type of immune cells ...

Alzheimer's disease, the leading cause of dementia, affects over 55 million people worldwide. The disease is characterized by ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

The medical community remains committed to improving treatment for those living with Alzheimer’s and other forms of dementia.

Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...

An ASU Ph.D. student is working to inform and bring awareness to Latinos about Alzheimer's disease and the resources ...